Published in Cancer Weekly, August 31st, 2010
"Tumours from BRCA1 and BRCA2 mutation carriers display distinctive pathological features that could be used to better discriminate...
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Cancer Weekly
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.